An experiment at SLAC’s X-ray laser provides new insight into the ultrafast motions of a muscle protein in a basic biochemical reaction.

A team led by Stanford University scientists is using software to breathe new life into results from past biological experiments at SLAC’s X-ray laser.

Developed at SLAC’s LCLS, it could also yield new information from hard-to-study samples in materials science, chemistry and other fields.

An X-ray laser experiment could lead to new drugs that lessen the side effects caused by powerful painkillers like morphine.

Research reveals that the bacterial immune system can better destroy viral attackers by saving genetic records of previously encountered viruses.

Scientists have assembled an exotic toolbox for experiments that tap into the brightest X-rays on the planet.

A new experimental station in development at SLAC will expand capabilities for atomic-scale explorations in human health, biology, energy and environmental science.

Discovery at SLAC's Synchrotron Could Lead to New Drug Designs, Treatments

William Weis, PhD, chairman and professor of photon science at the Department of Energy's SLAC National Accelerator Laboratory, has been appointed chairman of the Department of Structural Biology in the Stanford School of Medicine.

Experiment at SLAC's X-ray Laser Opens Door to Exploring Cell Interiors

By finding surprising similarities in the way immune system defenders bind to disease-causing invaders, a new study may help scientists develop new treatments.

Researchers have discovered that an Ebola virus protein can transform into three distinct structures with different functions. This rather uncommon property provides new clues for the development of potential drugs for deadly hemorrhagic fever.